Seqens

SEQENS is a worldwide leader in the development and production of pharmaceutical solutions leveraging a strong integrated network of 15 GMP and non-GMP manufacturing sites, 9 R&D centers and 3300 employees in 9 countries. As an integrated player across the value chain - from raw materials to active ingredients and from research and development to industrialization - SEQENS offers a broad portfolio of APIs, pharmaceutical intermediates and excipients, develops and industrializes the most demanding molecules, and relies on its ability to innovate and implement the best available technologies.